Welcome to Endpoints News’ manufacturing briefs, where we bring you essential news on new builds, collaborations, recalls and more.
Baxter said that it is increasing manufacturing at its sites outside of North Carolina, where a site in North Cove was flooded by Hurricane Helene. The company also said it is boosting its US allocation levels of its high-demand intravenous fluids in the country for direct customers from 40% to 60% and for distributors from 10% to 60% starting Oct. 9.
MilliporeSigma opened a €290 million ($317 million) biosafety testing facility in Rockville, MD, making the 23,000-square-meter build its largest investment in contract testing in the company’s history. The move consolidates work previously done in four separate buildings into one.
The Sabin Vaccine Institute delivered about 700 doses of its investigational Marburg vaccine to Rwanda for a Phase 2 trial that would also recruit frontline workers. As part of its outbreak response, the institute will deliver additional doses following a request from the Rwandan government.
CDMO Cellipont Bioservices and Mongoose Bio signed an agreement to work together on Mongoose’s T-cell based therapies targeting solid cancers. Mongoose’s lead drug is an autologous TCR-T cell therapy directed against an undisclosed target that is immunogenic and expressed in many solid tumors.
ACG plans to upgrade its Croatian operations with an expansion that includes increased production capacity as well as the opening of new warehousing and slitting facilities. The latest upgrade will be completed by the end of this year.
CDMO Naobios and the European Vaccine Initiative have teamed up as part of the Inno4Vac project to manufacture an RSV challenge agent. The financial terms of the agreement weren’t disclosed.
Cellipont Bioservices has named Darren Head, who is also chairman of the board, as CEO of the company. Cellipont also announced a minority growth equity investment from HealthQuest Capital and GPP, Cellipont’s majority investor.
Medical technology company BD and the CDMO ten23 health have agreed to collaborate to develop a new way to track prefillable syringes. As part of the partnership, BD will try out an RFID-based solution to improve the manufacturing process efficiency and tracing individual syringes with a unique serial number.